Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Engaged Capital launches with $85M seed investment from Grosvenor Capital Management

Wednesday, September 12, 2012

Glenn W. Welling
Bailey McCann, Opalesque New York:

Engaged Capital, an activist investment firm focused on investing in small and mid-cap North American equities, announced a strategic partnership with Grosvenor Capital Management, one of the oldest and largest global alternative investment managers, with over $22bn in assets under management. The Engaged deal is the second strategic partnership entered into by Grosvenor since it launched its current Emerging Manager program at the beginning of the year.

Engaged Capital was founded this month by Glenn W. Welling, a former Principal and Managing Director at Relational Investors. Engaged makes concentrated investments in undervalued public companies and through a constructive engagement process serves as the catalyst for strategic change and shareholder value creation. Welling has over 20 years of experience in activist investing and providing business advisory services to companies to help them increase shareholder value and will be bringing his team from Relational into the new fund.

Prior to his work at Relational, Welling ran the Buy-side Insights Group at Credit Suisse, where he helped many of the bank’s largest clients ensure their decisions and actions created value for their shareholders. Before Credit Suisse, Welling was a partner at HOLT Value Associates, where he ran a similar business. He joined Relational in 2008, bringing with him some of the bankers from his team at Credit Suisse to help grow the firm’s large-cap fund ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t